ロード中...
Hyperbaric Oxygen Preconditioning Provides Preliminary Protection Against Doxorubicin Cardiotoxicity
BACKGROUND: Doxorubicin (DOX) is generally recognized to have important cardiotoxic side effects. Studies are contradictory about the interaction between hyperbaric oxygen (HBO(2)) therapy and doxorubicin-induced cardiomyotoxicity. Recent data suggests that HBO(2) therapy can lead to preconditioning...
保存先:
| 出版年: | Acta Cardiol Sin |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taiwan Society of Cardiology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5364156/ https://ncbi.nlm.nih.gov/pubmed/28344418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS20160404B |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|